(Q36322698)

13 August 2017

Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis (English)

1 reference

13 August 2017

0 references

Sara Weis

1

1 reference

13 August 2017

Jianhua Cui

series ordinal

2

1 reference

13 August 2017

Leo Barnes

series ordinal

3

1 reference

13 August 2017

David Cheresh

series ordinal

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

13 August 2017

7

1 reference

inferred from page(s)

published in

Journal of Cell Biology

1 reference

13 August 2017

167

1 reference

13 August 2017

223-229

1 reference

13 August 2017

2

1 reference

Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

The biology of VEGF and its receptors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Vascular permeability factor (VPF, VEGF) in tumor biology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

SU1498, an inhibitor of vascular endothelial growth factor receptor 2, causes accumulation of phosphorylated ERK kinases and inhibits their activity in vivo and in vitro

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Tumor regression by targeted gene delivery to the neovasculature

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2172541

Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15504909

12 December 2020

inferred from PubMed ID database lookup

Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15504909

12 December 2020

inferred from PubMed ID database lookup

Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15504909

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1083/JCB.200408130

1 reference

13 August 2017

1 reference

13 August 2017

1 reference